• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-氨基酸氧化酶抑制剂的合成与生物学评价

Synthesis and biological evaluation of D-amino acid oxidase inhibitors.

作者信息

Ferraris Dana, Duvall Bridget, Ko Yao-Sen, Thomas Ajit G, Rojas Camilo, Majer Pavel, Hashimoto Kenji, Tsukamoto Takashi

机构信息

MGI Pharma, Inc.

出版信息

J Med Chem. 2008 Jun 26;51(12):3357-9. doi: 10.1021/jm800200u. Epub 2008 May 29.

DOI:10.1021/jm800200u
PMID:18507366
Abstract

D-amino acid oxidase (DAAO) catalyzes the oxidation of D-amino acids including d-serine, a full agonist at the glycine site of the NMDA receptor. A series of benzo[ d]isoxazol-3-ol derivatives were synthesized and evaluated as DAAO inhibitors. Among them, 5-chloro-benzo[ d]isoxazol-3-ol (CBIO) potently inhibited DAAO with an IC50 in the submicromolar range. Oral administration of CBIO in conjunction with d-serine enhanced the plasma and brain levels of d-serine in rats compared to the oral administration of d-serine alone.

摘要

D-氨基酸氧化酶(DAAO)催化包括D-丝氨酸在内的D-氨基酸的氧化反应,D-丝氨酸是N-甲基-D-天冬氨酸受体甘氨酸位点的完全激动剂。合成了一系列苯并[d]异恶唑-3-醇衍生物,并对其作为DAAO抑制剂进行了评估。其中,5-氯-苯并[d]异恶唑-3-醇(CBIO)能有效抑制DAAO,其半数抑制浓度(IC50)在亚微摩尔范围内。与单独口服D-丝氨酸相比,CBIO与D-丝氨酸联合口服可提高大鼠血浆和脑内D-丝氨酸水平。

相似文献

1
Synthesis and biological evaluation of D-amino acid oxidase inhibitors.D-氨基酸氧化酶抑制剂的合成与生物学评价
J Med Chem. 2008 Jun 26;51(12):3357-9. doi: 10.1021/jm800200u. Epub 2008 May 29.
2
Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine.D-氨基酸氧化酶抑制剂与D-丝氨酸联合使用可增强其在减轻地佐环平给药后前脉冲抑制缺陷方面的疗效。
Biol Psychiatry. 2009 Jun 15;65(12):1103-6. doi: 10.1016/j.biopsych.2009.01.002. Epub 2009 Feb 12.
3
Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.用D-氨基酸氧化酶抑制剂调节NMDA受体功能:了解苯环利定处理小鼠模型中的功能活性
Neurochem Res. 2016 Feb;41(1-2):398-408. doi: 10.1007/s11064-016-1838-8. Epub 2016 Feb 8.
4
Contributions of spinal D-amino acid oxidase to bone cancer pain.脊髓 D-氨基酸氧化酶对骨癌痛的贡献。
Amino Acids. 2012 Nov;43(5):1905-18. doi: 10.1007/s00726-012-1390-z. Epub 2012 Sep 21.
5
Interactions of the potent D-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia.强效 D-氨基酸氧化酶抑制剂 CBIO 与吗啡在疼痛和镇痛耐受中的相互作用。
Neuropharmacology. 2012 Sep;63(3):460-8. doi: 10.1016/j.neuropharm.2012.04.030. Epub 2012 May 2.
6
Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.抑制鼠脑 D-氨基酸氧化酶对 NMDA 受体功能的调制。
Neuropharmacology. 2011 Oct-Nov;61(5-6):1001-15. doi: 10.1016/j.neuropharm.2011.06.029. Epub 2011 Jul 7.
7
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.新型3-羟基喹啉-2(1H)-酮系列强效D-氨基酸氧化酶(DAAO)抑制剂的发现、构效关系及药代动力学研究
J Med Chem. 2009 Jun 11;52(11):3576-85. doi: 10.1021/jm900128w.
8
Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect.给猴子口服D-丙氨酸可显著提高血浆和脑脊液水平,但实验性D-氨基酸氧化酶抑制剂的作用微乎其微。
J Psychopharmacol. 2016 Sep;30(9):887-95. doi: 10.1177/0269881116652586. Epub 2016 Jun 10.
9
The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.新型D-氨基酸氧化酶抑制剂化合物8[4H-噻吩并[3,2-b]吡咯-5-羧酸]与D-丝氨酸的行为和神经化学效应
J Pharmacol Exp Ther. 2009 Mar;328(3):921-30. doi: 10.1124/jpet.108.147884. Epub 2008 Dec 16.
10
Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.口服 D-丝氨酸在 D-氨基酸氧化酶敲除小鼠中的药代动力学。
Drug Metab Dispos. 2012 Nov;40(11):2067-73. doi: 10.1124/dmd.112.046482. Epub 2012 Jul 26.

引用本文的文献

1
Symptomatic and cognitive effects of D-amino acid oxidase inhibitors in patients with schizophrenia: a meta-analysis of double-blind randomized controlled trials.D-氨基酸氧化酶抑制剂对精神分裂症患者的症状及认知影响:双盲随机对照试验的荟萃分析
Schizophrenia (Heidelb). 2025 May 6;11(1):73. doi: 10.1038/s41537-025-00604-2.
2
DAAO Mutant Sites among Different Mice Strains and Their Effects on Enzyme Activity.不同小鼠品系中DAAO的突变位点及其对酶活性的影响。
Protein J. 2025 Feb;44(1):102-112. doi: 10.1007/s10930-024-10235-8. Epub 2024 Nov 2.
3
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment.
氧化和线粒体功能障碍框架下的精神分裂症突触病理学与抗精神病治疗:临床与治疗的转化要点
Antioxidants (Basel). 2023 Apr 21;12(4):975. doi: 10.3390/antiox12040975.
4
Determination of D-serine and D-alanine Tissue Levels in the Prefrontal Cortex and Hippocampus of Rats After a Single Dose of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, with Potential Antipsychotic and Antidepressant Properties.测定单剂量苯甲酸钠(一种具有潜在抗精神病和抗抑郁特性的 D-氨基酸氧化酶抑制剂)后大鼠前额叶皮层和海马中的 D-丝氨酸和 D-丙氨酸组织水平。
Neurochem Res. 2023 Jul;48(7):2066-2076. doi: 10.1007/s11064-023-03884-1. Epub 2023 Feb 14.
5
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II.D-多巴是谷氨酸羧肽酶II的一种强效、口服生物可利用的变构抑制剂。
Pharmaceutics. 2022 Sep 23;14(10):2018. doi: 10.3390/pharmaceutics14102018.
6
Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.靶向 D-氨基酸氧化酶(DAAO)治疗精神分裂症:原理和研究现状。
CNS Drugs. 2022 Nov;36(11):1143-1153. doi: 10.1007/s40263-022-00959-5. Epub 2022 Oct 4.
7
Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics.D-氨基酸治疗抵抗性精神分裂症的合理性和转化意义:从神经生物学到临床。
Biomolecules. 2022 Jun 29;12(7):909. doi: 10.3390/biom12070909.
8
Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia.节奏发现:苯甲酸钠治疗难治性精神分裂症的剂量探索和作用机制临床试验方案。
Trials. 2021 Dec 13;22(1):918. doi: 10.1186/s13063-021-05890-6.
9
Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients With Schizophrenia.直接和间接靶向甘氨酸调节位点以调节NMDA受体功能,满足精神分裂症患者未被满足的医疗需求。
Front Psychiatry. 2021 Oct 1;12:742058. doi: 10.3389/fpsyt.2021.742058. eCollection 2021.
10
D-cysteine is an endogenous regulator of neural progenitor cell dynamics in the mammalian brain.D-半胱氨酸是哺乳动物大脑神经祖细胞动态的内源性调节剂。
Proc Natl Acad Sci U S A. 2021 Sep 28;118(39). doi: 10.1073/pnas.2110610118.